LeMaitre Vascular, Inc. (LMAT) Tops Q2 EPS by 3c

LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q2 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $18.2 million versus the consensus estimate of $17.5 million.

For earnings history and earnings-related data on LeMaitre Vascular, Inc. (LMAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c